Bo Chen

651 East Dongfeng Road
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 86 publications

Corrigendum to "Global burden, temporal trends and cross-national inequalities of the comorbidity between depressive disorder and hormone-dependent tumors in women of reproductive ages from 1990 to 2021: A population-based analysis with projections to 2036" [J. Affect. Disord. 405 (2026) 121635].

Corrigendum to "Global burden, temporal trends and cross-national inequalities of the comorbidity between depressive disorder and hormone-dependent tumors in women of reproductive ages from 1990 to 2021: A population-based analysis with projections to 2036" [J. Affect. Disord. 405 (2026) 121635].

Journal: Journal of affective disorders

Published: April 29, 2026

Single-cell profiling reveals peripheral blood immune landscape remodelling in breast cancer lymph node metastasis.

Single-cell profiling reveals peripheral blood immune landscape remodelling in breast cancer lymph node metastasis.

Journal: Clinical and translational medicine

Published: February 02, 2026

Neoadjuvant Taxane Plus Trastuzumab and Pertuzumab With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The Randomized Noninferiority Phase III neoCARHP Trial.

Neoadjuvant Taxane Plus Trastuzumab and Pertuzumab With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The Randomized Noninferiority Phase III neoCARHP Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 23, 2026

circPARPBP promotes cancer stemness and chemoresistance in triple-negative breast cancer through recruiting SRCAP complex to activate CCL20 transcription.

circPARPBP promotes cancer stemness and chemoresistance in triple-negative breast cancer through recruiting SRCAP complex to activate CCL20 transcription.

Journal: Oncogene

Published: September 23, 2025

CircPLK1 upregulates ETS1 to confer anthracycline resistance in triple-negative breast cancer.

CircPLK1 upregulates ETS1 to confer anthracycline resistance in triple-negative breast cancer.

Journal: Journal of translational internal medicine

Published: September 02, 2025

Dosimetric advantages and clinical feasibility of a novel lateral decubitus position for left breast cancer patients undergoing PORT.

Dosimetric advantages and clinical feasibility of a novel lateral decubitus position for left breast cancer patients undergoing PORT.

Journal: Radiation oncology (London, England)

Published: August 12, 2025

Orbital Metastases of Breast Cancer: Case Report and Review of the Literature.

Orbital Metastases of Breast Cancer: Case Report and Review of the Literature.

Journal: Oncology research

Published: May 15, 2025

Characterizing neurofibromin 1-altered breast cancer through genomic, functional, and clinical analyses.

Characterizing neurofibromin 1-altered breast cancer through genomic, functional, and clinical analyses.

Journal: Virchows Archiv : an international journal of pathology

Published: April 29, 2025

Independent effects of mental health disorders on breast cancer and their mediating factors: evidence from NHANES and two-step Mendelian randomization.

Independent effects of mental health disorders on breast cancer and their mediating factors: evidence from NHANES and two-step Mendelian randomization.

Journal: Discover oncology

Published: March 17, 2025

Sitravatinib Targets TYRO3 to Augment the Antitumor Immune Response of PD-1 Blockade in Hepatocellular Carcinoma.

Sitravatinib Targets TYRO3 to Augment the Antitumor Immune Response of PD-1 Blockade in Hepatocellular Carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 26, 2024

Neoadjuvant anlotinib/sintilimab plus chemotherapy in triple-negative breast cancer (NeoSACT): Phase 2 trial.

Neoadjuvant anlotinib/sintilimab plus chemotherapy in triple-negative breast cancer (NeoSACT): Phase 2 trial.

Journal: Cell reports. Medicine

Published: October 27, 2024

Global burden, temporal trends and cross-national inequalities of the comorbidity between depressive disorder and hormone-dependent tumors in women of reproductive ages from 1990 to 2021: A population-based analysis with projections to 2036.

Global burden, temporal trends and cross-national inequalities of the comorbidity between depressive disorder and hormone-dependent tumors in women of reproductive ages from 1990 to 2021: A population-based analysis with projections to 2036.

Journal: Journal of affective disorders

Published: August 30, 2024

Showing 1-12 of 86

Last Updated: 09/26/2026